首页 > 市场调查报告书 > 製药

DDS

市场调查报告书

商品编码

1620218

全球注射包装和组件市场规模（按包装材料、注射、组件、剂量、地区、范围和预测）

Global Injectable Packaging And Component Market Size By Packaging Material, By Parenteral, By Component, By Dosage, By Geographic Scope And Forecast

出版日期: 2024年11月02日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格

简介目录

注射包装及组件市场规模及预测

近年来，注射剂包装和组件的市场规模一直以适度的速度增长，增长率相当可观，预计该市场在预测期内（即 2021-2028 年）将显着增长。

注射药物包装可防止其成分进入外部环境参数。我们的产品线包括西林瓶、药筒、预充式註射器和密封件，以及其他注射包装和组件。药物使用的增加、对个人化医疗的重视以及针对慢性疾病的新疗法的出现推动了製药业的成长。该研究报告对全球注射药品包装和组件市场进行了全面评估。它对关键细分市场、趋势、市场推动因素、阻碍因素、竞争格局以及在市场中发挥关键作用的因素进行了全面分析。

全球注射包装与组件市场定义

注射包装透过填充药物和成分并密封到一个紧凑的机器框架中，消除了与传统加工相关的几个步骤和额外成本。重量轻、无颗粒加工、耐破损、易于打开和回收能力是注射包装与玻璃包装的区别因素。注射药物比口服药物更复杂，并且更可能与环境暴露相互作用。结果表明，与活性物质接触的容器对药物没有影响。注射药物的包装方式应使其成分不干扰外部环境参数。

西林瓶、药筒、预充式註射器、密封件以及其他注射包装和组件产品。注射包装和组件分为小瓶、密封件、药筒、注射器、安瓿等。小瓶是一种小容器，通常由塑胶或玻璃製成。与标准采血管不同，它们的形状像管子或瓶子，底部平坦。根据您的特定存放和处理需求，小瓶可配备各种瓶盖。药筒是装在註射器中用来给病人注射的物质的容器。

将药筒插入註射器主体的开口中。药物密封在金属注射器内的药筒中。安瓿是储存不稳定元素的理想选择，因为密封可以保护化学溶液免受污染。为了保持药物稳定，药厂在插入药物之前先排除安瓿中的空气。包装能够可靠地保护产品免受任何可能降低其性能或功效的外部因素的影响，例如光、湿度、氧气、生物污染和伪造。

全球注射包装和组件市场概览

对生物製药和药品製造核心能力的关注、企业搬迁的需要、拥有成本以及作为组合产品一部分的组件的重要性日益增加，正在推动注射剂包装和组件的发展，以下是四个主要因素。这些发展推动了对更高耐用性的需求。此外，药物使用量的增加、对个人化医疗的日益关注以及慢性病创新疗法的出现正在推动製药业的成长。

由于製药和生物技术行业的进步以及材料科学和製造方法的发展，注射包装和组件市场正在发生重大变化。全球注射剂包装和组件市场得到了成长的支撑，包括新兴经济体中产阶级的不断壮大、注射剂在药品管道中所占占有率的增加以及癌症发病率的上升。

此外，患者自我管理需求的增加、包括细胞和基因疗法在内的自然疗法的多样化，以及推动整体市场成长的 COVID-19 疫苗的前沿发展，都推动了药品包装的需求。口服固体製剂完全占据市场主导地位，注射剂也正在快速成长。然而，有关药品包装的严格法律法规阻碍了市场的成长。

随着监管要求的不断提高以及对患者安全的关注，当前的注射剂包装和组件市场面临着如何尽快有效地将这种产品推向市场的课题，这阻碍了全球注射剂包装和组件市场的发展。随着新技术提高玻璃的稳定性、无菌性和保质期，製药公司正在转向采用柔性结构来包装注射药物，从而推动预测期内的市场成长。

Injectable drug packaging so that its constituents do not intrude with external environmental parameters. There are vials, cartridges, prefilled syringes, seals, as well as other injectable packaging and component product lines. The pharmaceutical industry's growth is fueled by increased medication use, a greater emphasis on personalized medicine, and the beginnings of new therapeutics for chronic health conditions. The Global Injectable Packaging And Component Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Injectable Packaging And Component Market Definition

Injectable packaging implicates filling and sealing drugs and components in a single compact machine frame, removing several of the steps and extra costs associated with conventional processing. Weight savings, particle-free processing, resistance to breakage, ease of opening, and recycling capacity differentiate injectable packaging from glass. Injectable drugs are more complicated than oral medications and can easily interact with environmental exposures. As an outcome, any container that makes contact with the active substance is demonstrated to not influence the drug. Injectable drug packaging is done in a way that its components do not interfere with outside environmental parameters.

Vials, cartridges and prefilled syringes, seals, as well as other injectable packaging and component products, are available. The Injectable Packaging and Components are classified as Vials, Seals, Cartridges, Syringes, Ampules, and Other. A vial is a small container that is generally made of plastic or glass. Unlike standard blood collection tubes, it is shaped like a tube or bottle and has a flat bottom. Vials are usable with a variety of caps to meet specific storage or handling necessities. A cartridge is a container of a substance used in a syringe to administer to a patient.

Insert the cartridge into the syringe body opening. The medicine is enclosed in a cartridge within the metal syringe. Ampoules are perfect for storing unstable elements because the seal protects the chemical from contamination. To ensure that the drug remains stable, drugs companies extract air from the ampoule before inserting the drug. The packaging ensures protection of the product from all external factors that degrade its performance or potency, including light, humidity, oxygen, biological contamination, as well as counterfeiting.

Global Injectable Packaging And Component Market Overview

The focus on biopharmaceutical and pharmaceutical manufacturing core competencies and the need for companies to move, the cost of ownership, and the growing significance of components as part of a combination product are the four major developments fueling the development of injectable packaging and components demand for higher durability. Moreover, Higher use of medicines, a growing focus on personalized medicine, and the rise of innovative therapies for chronic conditions are driving pharmaceutical industry growth.

The Injectable Packaging And Component Market is changing significantly as a result of the progression of the pharmaceutical and biotechnology industries, as well as developments in material science and manufacturing methods. The Global Injectable Packaging And Component Market is supported by growth such as the rising middle class in developing economies, the increasing share of injectables in the drug pipeline, a rise in cancer incidence, etc.

Furthermore, Pharmaceutical packaging essentials are influenced by using the increasing need for patient self-management and the increasing variety of natural therapies, including cell and gene therapies, as well as cutting-edge developments in COVID-19 vaccines leading to drive the overall growth of the market. Oral solid dosage forms completely dominate the market, and injectable medicines are increasing at a high rate. Nonetheless, the market's growth is hampered by strict laws and restrictions governing drug packaging.

With rising regulatory requirements and the prominence of patient safety, the current Injectable Packaging And Component Market is facing problems to bring this product to the market as quickly and effectively as possible leading to hindering the Global Injectable Packaging and Component Market. As new technology progresses stability, sterility, and shelf life over the glass, pharmaceutical companies are switching toward flexible structures for packaging injectable medicinal products leading to a rise in the growth of the market throughout the projected period.

Global Injectable Packaging And Component Market Segmentation Analysis

The Global Injectable Packaging And Component Market is Segmented on the basis of Packaging Material, Parenteral, Component, Dosage, And Geography.

Injectable Packaging And Component Market, By Packaging Material

Glass
Metal

Based on Packaging Material, The market is segmented into Glass and Metal. Glass has the highest growing segment of the Global Injectable Packaging and Components Market. Because of its high transparency, its contents are easily monitored. And it is highly resistive to air and moisture, it provides better protection as compared to metal over the projected period.

Injectable Packaging And Component Market, By Parenteral

Small Volume Parenteral
Large Volume Parenteral

Based on Parenteral, The market is segmented into Small Volume Parenteral and Large Volume Parenteral. The Small Volume Parenteral has the highest growing segment of the Global Injectable Packaging and Components Market. To establish specific parameters, establish drug quality, and maintain the drug's shelf life as compared to the large volume parenteral over the forecasted period.

Injectable Packaging And Component Market, By Component

Cartridges
Ampules
Vials
Syringes
Seals
Other

Based on Component, The market is segmented into Cartridges, Ampules, Vials, Syringes, Seals, Other. Vials have the largest growing segment of the Global Injectable Packaging and Components Market. The most common packaging material for liquid and freeze-dried injectables is glass vials. Plastic vials are less frequently used due to the ease with which glass is sterilized and transferred to aseptic environments over the projected period.

Injectable Packaging And Component Market, By Dosage

Single Dosage
Multi Dosage

Based on Dosage, The market is segmented into Single Dosage and Multi Dosage. A Single-Dose has the largest growing segment of the Global Injectable Packaging and Components Market A single dosage of a parenteral preparation that does not need to be tested for antimicrobial efficacy. A single dosage is designed to be used with a single patient for a single injection leading to an increase in the growth of the market globally.

Injectable Packaging And Component Market, By Geography

North America
Europe
Asia Pacific
Rest of the world
On the basis of Geography, The Global Injectable Packaging And Component Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America has the highest growing segment of the Global Injectable Packaging and Components Market. Factors include the rising incidence of chronic diseases, the growth of the Injectable Packaging And Component Market, and the increasing demands for self-injection devices over the forecasted period.

Key Players

The "Global Injectable Packaging And Component Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such as
West Pharmaceutical Services, Inc., Gerresheimer AG, Actiza Pharmaceutical Private Limited. Ypsomed Group, Injectapak, Pace Biotech, Aptar Pharma, and Datwyler Holding Inc.

Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis.

1. INTRODUCTION OF GLOBAL INJECTABLE PACKAGING AND COMPONENT MARKET

1.1. Overview of the Market
1.2. Scope of Report
1.3. Assumptions

2. EXECUTIVE SUMMARY

3. RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1. Data Mining
3.2. Validation
3.3. Primary Interviews
3.4. List of Data Sources

4. GLOBAL INJECTABLE PACKAGING AND COMPONENT MARKET OUTLOOK

4.1. Overview
4.2. Market Dynamics
- 4.2.1. Drivers
- 4.2.2. Restraints
- 4.2.3. Opportunities
- 4.2.4. Challenges
4.3. Porters Five Force Model
4.4. Value Chain Analysis

5. GLOBAL INJECTABLE PACKAGING AND COMPONENT MARKET, BY PACKAGING MATERIAL

5.1. Overview
5.2. Glass
5.3. Metal

6. GLOBAL INJECTABLE PACKAGING AND COMPONENT MARKET, BY PARENTERAL

6.1. Overview
6.2. Small Volume Parenteral
6.3. Large Volume Parenteral

7. GLOBAL INJECTABLE PACKAGING AND COMPONENT MARKET, BY COMPONENT

7.1. Overview
7.2. Cartridges
7.3. Syringes
7.4. Vials
7.5. Ampules
7.6. Seals
7.7. Other

8. GLOBAL INJECTABLE PACKAGING AND COMPONENT MARKET, BY DOSAGE

8.1. Overview
8.2. Single Dosage
8.3. Multi Dosage

9. GLOBAL INJECTABLE PACKAGING AND COMPONENT MARKET, BY GEOGRAPHY

9.1 Overview
9.2 North America
- 9.2.1 U.S.
- 9.2.3 Canada
- 9.2.4 Mexico
9.3 Europe
- 9.3.1 Germany
- 9.3.2 U.K.
- 9.3.3 France
- 9.3.4 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Rest of Asia Pacific
9.5 Rest of the World
- 9.5.1 Latin America
- 9.5.2 Middle East and Africa

10. GLOBAL INJECTABLE PACKAGING AND COMPONENT MARKET COMPETITIVE LANDSCAPE

10.1. Overview
10.2. Company Market Ranking
10.3. Key Development Strategies

11. COMPANY PROFILES

11.1 West Pharmaceutical Services
- 11.1.1 Overview
- 11.1.2 Financial Performance
- 11.1.3 Product Outlook
- 11.1.4 Key Developments
11.2 Gerresheimer AG
- 11.2.1 Overview
- 11.2.2 Financial Performance
- 11.2.3 Product Outlook
- 11.2.4 Key Developments
11.3 Actiza Pharmaceutical Private Limited
- 11.3.1 Overview
- 11.3.2 Financial Performance
- 11.3.3 Product Outlook
- 11.3.4 Key Developments
11.4 Ypsomed Group
- 11.4.1 Overview
- 11.4.2 Financial Performance
- 11.4.3 Product Outlook
- 11.4.4 Key Developments
11.5 Datwyler Holding Inc.
- 11.5.1 Overview
- 11.5.2 Financial Performance
- 11.5.3 Product Outlook
- 11.5.4 Key Developments
11.6 Injectapak
- 11.6.1 Overview
- 11.6.2 Financial Performance
- 11.6.3 Product Outlook
- 11.6.4 Key Developments
11.7 Pace Biotech
- 11.7.1 Overview
- 11.7.2 Financial Performance
- 11.7.3 Product Outlook
- 11.7.4 Key Developments
11.8 Aptar Pharma
- 11.8.1 Overview
- 11.8.2 Financial Performance
- 11.8.3 Product Outlook
- 11.8.4 Key Developments